...
首页> 外文期刊>American Journal of Translational Research >Restoration of bone defects using modified heterogeneous deproteinized bone seeded with bone marrow mesenchymal stem cells
【24h】

Restoration of bone defects using modified heterogeneous deproteinized bone seeded with bone marrow mesenchymal stem cells

机译:使用改良的异种脱蛋白骨植入骨髓间充质干细胞修复骨缺损

获取原文

摘要

The aim of the present study was to investigate the effect of modified heterogeneous deproteinized bone combined with bone marrow mesenchymal stem cells (BMSCs) in the restoration of a validated bone defect model. BMSCs were identified by flow cytometry and multilineage differentiation assay. The structural features of the modified heterogeneous deproteinized bone scaffold and biocompatibility between BMSCs and the scaffold were confirmed by scanning electron microscope (SEM) detection. The cytotoxicity of the modified heterogeneous deproteinized bone scaffolds were detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenytetrazolium bromide (MTT) assay. SEM detection proved that modified heterogeneous deproteinized bone scaffold had no negative impact on the proliferation of BMSCs. MTT assay results demonstrated that the scaffold had no apparent cytotoxicity. Biomechanical detection showed that the stiffness and ultimate loading of tibias in the scaffold + BMSCs group were significantly higher than those of the scaffold alone group (P < 0.05) and the control group (P < 0.01). Histological analyses confirmed that the greatest quantity of new bone was generated in the scaffold + BMSCs group, when compared with all other groups, at 8 weeks’ post-operation. The bone mineral density (BMD) in the scaffold + BMSC group was significantly higher than that of the scaffold alone group (P < 0.05) and the control group (P < 0.01). Fluorometric analyses confirmed the presence of BMSCs at high concentration within the bone defect areas in the scaffold + BMSCs group at 4 weeks after transplantation. These findings suggest that the modified heterogeneous deproteinized bone scaffold seeded with BMSCs can effectively enhance the restoration of bone defects.
机译:本研究的目的是研究改良的异种脱蛋白骨与骨髓间充质干细胞(BMSCs)联合在验证的骨缺损模型中的作用。通过流式细胞术和多谱系分化测定法鉴定BMSC。通过扫描电子显微镜(SEM)检测,证实了修饰的异质脱蛋白骨支架的结构特征以及BMSC与支架之间的生物相容性。通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯并四唑鎓溴化物(MTT)测定来检测修饰的异质脱蛋白骨支架的细胞毒性。 SEM检测证明,修饰的异种脱蛋白骨支架对BMSCs的增殖没有负面影响。 MTT测定结果表明该支架没有明显的细胞毒性。生物力学检测表明,支架+ BMSCs组胫骨的刚度和最终载荷明显高于单纯支架组(P <0.05)和对照组(P <0.01)。组织学分析证实,与所有其他组相比,支架+ BMSCs组在术后8周时产生的新骨量最多。支架+ BMSC组的骨矿物质密度(BMD)明显高于单独支架组(P <0.05)和对照组(P <0.01)。荧光分析证实,移植后4周,支架+ BMSCs组的骨缺损区域内存在高浓度的BMSC。这些发现表明,用骨髓间充质干细胞播种的改良异质脱蛋白骨支架可以有效地增强骨缺损的修复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号